Return On Assets of ImmunityBio, Inc. from 31 Mar 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ImmunityBio, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2016 to 30 Sep 2025.
  • ImmunityBio, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -87%, a 37% increase year-over-year.
  • ImmunityBio, Inc. annual Return On Assets for 2024 was -104%, a 30% increase from 2023.
  • ImmunityBio, Inc. annual Return On Assets for 2023 was -148%, a 27% decline from 2022.
  • ImmunityBio, Inc. annual Return On Assets for 2022 was -117%, a 3.8% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

ImmunityBio, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -87% +50% +37% 01 Jul 2025 30 Sep 2025
Q2 2025 -101% +33% +25% 01 Apr 2025 30 Jun 2025
Q1 2025 -109% +38% +26% 01 Jan 2025 31 Mar 2025
Q4 2024 -104% +45% +30% 01 Oct 2024 31 Dec 2024
Q3 2024 -137% -9% -7% 01 Jul 2024 30 Sep 2024
Q2 2024 -134% +6% +4.4% 01 Apr 2024 30 Jun 2024
Q1 2024 -148% -23% -18% 01 Jan 2024 31 Mar 2024
Q4 2023 -148% -31% -27% 01 Oct 2023 31 Dec 2023
Q3 2023 -128% -24% -23% 01 Jul 2023 30 Sep 2023
Q2 2023 -140% -32% -30% 01 Apr 2023 30 Jun 2023
Q1 2023 -125% -13% -11% 01 Jan 2023 31 Mar 2023
Q4 2022 -117% +5% +3.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -105% +25% +19% 01 Jul 2022 30 Sep 2022
Q2 2022 -108% +16% +13% 01 Apr 2022 30 Jun 2022
Q1 2022 -112% +1% +1% 01 Jan 2022 31 Mar 2022
Q4 2021 -122% -19% -19% 01 Oct 2021 31 Dec 2021
Q3 2021 -129% -41% -47% 01 Jul 2021 30 Sep 2021
Q2 2021 -124% -60% -95% 01 Apr 2021 30 Jun 2021
Q1 2021 -113% -67% -144% 01 Jan 2021 31 Mar 2021
Q4 2020 -103% -70% -218% 01 Oct 2020 31 Dec 2020
Q3 2020 -88% -51% -136% 01 Jul 2020 30 Sep 2020
Q2 2020 -64% -24% -61% 01 Apr 2020 30 Jun 2020
Q1 2020 -46% -3% -7.5% 01 Jan 2020 31 Mar 2020
Q4 2019 -32% +14% +31% 01 Oct 2019 31 Dec 2019
Q3 2019 -37% +9% +20% 01 Jul 2019 30 Sep 2019
Q2 2019 -39% +3% +8% 01 Apr 2019 30 Jun 2019
Q1 2019 -43% -6% -15% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% -13% -37% 01 Oct 2018 31 Dec 2018
Q3 2018 -46% -14% -44% 01 Jul 2018 30 Sep 2018
Q2 2018 -43% -10% -29% 01 Apr 2018 30 Jun 2018
Q1 2018 -38% -2% -6.1% 01 Jan 2018 31 Mar 2018
Q4 2017 -34% +2% +4.9% 01 Oct 2017 31 Dec 2017
Q3 2017 -32% +3% +9.1% 01 Jul 2017 30 Sep 2017
Q2 2017 -33% +5% +13% 01 Apr 2017 30 Jun 2017
Q1 2017 -35% +41% +54% 01 Jan 2017 31 Mar 2017
Q4 2016 -36% 01 Oct 2016 31 Dec 2016
Q3 2016 -35% 01 Jul 2016 30 Sep 2016
Q2 2016 -38% 01 Apr 2016 30 Jun 2016
Q1 2016 -77% 01 Jan 2016 31 Mar 2016

ImmunityBio, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -104% +45% +30% 01 Jan 2024 31 Dec 2024
2023 -148% -31% -27% 01 Jan 2023 31 Dec 2023
2022 -117% +5% +3.8% 01 Jan 2022 31 Dec 2022
2021 -122% +1% +0.49% 01 Jan 2021 31 Dec 2021
2020 -122% -45% -58% 01 Jan 2020 31 Dec 2020
2019 -78% -31% -66% 01 Jan 2019 31 Dec 2019
2018 -47% -13% -37% 01 Jan 2018 31 Dec 2018
2017 -34% +2% +4.9% 01 Jan 2017 31 Dec 2017
2016 -36% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.